Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

AML (Acute Myelogenous Leukemia) Clinical Trials

2 recruiting trials for AML (Acute Myelogenous Leukemia). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors

Recruiting Trials

RECRUITINGEarly Phase 1NCT07126782

The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT

The purpose of this study is to evaluate the efficacy and safety of allogeneic γδ T cells in patients with MRD-positive AML after allo-HSCT.

Sponsor: Institute of Hematology & Blood Diseases Hospital, ChinaEnrolling: 101 location
RECRUITINGPhase 1NCT06835140

CD123-CD16-NK Cells Immunotherapy for AML

The goal of this clinical trial is to evaluate the effectiveness of CD123-CD16 bispecific antibody-modified NK cells in treating patients with CD123-positive relapsed or...

Sponsor: Chunji GaoEnrolling: 91 location